The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 05, 2014
Filed:
Jun. 04, 2012
Suleyman Bahceci, San Mateo, CA (US);
William Bajjalieh, San Francisco, CA (US);
Jeff Chen, San Francisco, CA (US);
Sergey Epshteyn, Fremont, CA (US);
Timothy Patrick Forsyth, Hayward, CA (US);
Tai Phat Huynh, New York, NY (US);
Byung Gyu Kim, San Mateo, CA (US);
James W. Leahy, San Leandro, CA (US);
Matthew Sangyup Lee, San Francisco, CA (US);
Gary L. Lewis, San Francisco, CA (US);
Morrison B. Mac, San Francisco, CA (US);
Grace Mann, San Mateo, CA (US);
Charles K. Marlowe, Emerald Hills, CA (US);
Brian Hugh Ridgway, Belmont, CA (US);
Joan C. Sangalang, Mountain View, CA (US);
Xian Shi, San Bruno, CA (US);
Craig Stacy Takeuchi, Burlingame, CA (US);
Yong Wang, Foster City, CA (US);
Suleyman Bahceci, San Mateo, CA (US);
William Bajjalieh, San Francisco, CA (US);
Jeff Chen, San Francisco, CA (US);
Sergey Epshteyn, Fremont, CA (US);
Timothy Patrick Forsyth, Hayward, CA (US);
Tai Phat Huynh, New York, NY (US);
Byung Gyu Kim, San Mateo, CA (US);
James W. Leahy, San Leandro, CA (US);
Matthew Sangyup Lee, San Francisco, CA (US);
Gary L. Lewis, San Francisco, CA (US);
Morrison B. Mac, San Francisco, CA (US);
Grace Mann, San Mateo, CA (US);
Charles K. Marlowe, Emerald Hills, CA (US);
Brian Hugh Ridgway, Belmont, CA (US);
Joan C. Sangalang, Mountain View, CA (US);
Xian Shi, San Bruno, CA (US);
Craig Stacy Takeuchi, Burlingame, CA (US);
Yong Wang, Foster City, CA (US);
Exelixis Patent Company LLC, South San Francisco, CA (US);
Abstract
The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Formula I to treat cancer.